Acute Myeloid Leukemia Refractory
specificAn acute myeloid leukemia that does not respond to treatment.
14
Centers
13
Active Trials
—
Cancer Funding
Top Centers for Acute Myeloid Leukemia Refractory(14)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive High-Volume Research Center | 74.5 |
| 2 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive High-Volume Research Center | 71.2 |
| 3 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 56.8 |
| 4 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 56.8 |
| 5 | NCI Clinical Active Research Program | 56.8 |
| 6 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 56.8 |
| 7 | Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program | 56.8 |
| 8 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program | 56.8 |
| 9 | University of Illinois Cancer CenterChicago, IL Active Research Program | 56.8 |
| 10 | Boston University Cancer CenterBoston, MA Active Research Program | 56.8 |
| 11 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive | 37.5 |
| 12 | NCI Comprehensive | 37.5 |
| 13 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 37.5 |
| 14 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive | 37.5 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →